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Vitiligo-Inducing Phenols Activate the Unfolded
Protein Response in Melanocytes Resulting in
Upregulation of IL6 and IL8
Siavash Toosi1, Seth J. Orlow1 and Prashiela Manga1
Vitiligo is characterized by depigmented skin patches caused by loss of epidermal melanocytes. Oxidative stress
may have a role in vitiligo onset, while autoimmunity contributes to disease progression. In this study, we
sought to identify mechanisms that link disease triggers and spreading of lesions. A hallmark of melanocytes at
the periphery of vitiligo lesions is dilation of the endoplasmic reticulum (ER). We hypothesized that oxidative
stress results in redox disruptions that extend to the ER, causing accumulation of misfolded peptides, which
activates the unfolded protein response (UPR). We used 4-tertiary butyl phenol and monobenzyl ether of
hydroquinone, known triggers of vitiligo. We show that expression of key UPR components, including the
transcription factor X-box-binding protein 1 (XBP1), is increased following exposure of melanocytes to phenols.
XBP1 activation increases production of immune mediators IL6 and IL8. Co-treatment with XBP1 inhibitors
reduced IL6 and IL8 production induced by phenols, while overexpression of XBP1 alone increased their
expression. Thus, melanocytes themselves produce cytokines associated with activation of an immune
response following exposure to chemical triggers of vitiligo. These results expand our understanding of the
mechanisms underlying melanocyte loss in vitiligo and pathways linking environmental stressors and
autoimmunity.
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INTRODUCTION
Vitiligo vulgaris (‘‘vitiligo’’) is an acquired disorder character-
ized by depigmented skin patches because of localized loss of
melanocytes. The etiology of vitiligo is not fully understood,
but an intricate interaction of biochemical, environmental,
genetic, and immunological factors contribute to its pathogen-
esis. A widely accepted model for the disease proposes that a
trigger induces melanocyte stress that cannot be overcome in
individuals susceptible to vitiligo. The initial stressors are not
known in most cases (idiopathic vitiligo) but studies suggest
that a common effect of the causative trauma is induction of
oxidative stress (Boissy and Manga, 2004). Nonetheless, in
certain patients, defined as having contact vitiligo, exposure to
a chemical trigger such as 4-tertiary butyl phenol (4-TBP) and
monobenzyl ether of hydroquinone (MBEH) is known to
initiate the disease, which is subsequently indistinguishable
from idiopathic vitiligo (Boissy and Manga, 2004). Individuals
are primarily exposed to these chemicals in workplaces such
as industries that manufacture phenols. One hypothesis
proposes that these agents act as a substrate for tyrosinase,
the rate-limiting enzyme for melanogenesis, because of their
structural similarity to tyrosine, which leads to the generation
of reactive semi-quinone free radicals, induction of cellular
stress (Boissy and Manga, 2004; Westerhof and d’Ischia,
2007), and cytotoxicity (Hariharan et al., 2010).
Stressed melanocytes undergo apoptosis while also
initiating targeting of melanocytes by the immune system. If
the immune response is sustained, presumably determined by
genetic factors, melanocyte death can be perpetuated, resulting
in spread of lesions to areas distant from the initial site. Evidence
for autoimmune-mediated disease progression in vitiligo includes
its association with other autoimmune conditions such as
type 1 diabetes; antibodies against melanocyte-specific anti-
gens (Naughton et al., 1983) in sera from patients; association
between vitiligo susceptibility and polymorphisms at im-
mune-related loci (Spritz, 2010); T-cell infiltration in margins
of active lesions (Badri et al., 1993; Le Poole et al., 1996);
and increased levels of multiple pro-inflammatory cytokines
in sera and tissue from vitiligo patients (Yu et al., 1997; Kemp
et al., 2001; Tu et al., 2003; Moretti et al., 2009).
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On contact with melanocytes, 4-TBP and MBEH induce
the production of reactive oxygen species (Boissy and Manga,
2004; Manga et al., 2006). We hypothesized that the
resulting oxidative stress leads to disruption of homeostasis
in the endoplasmic reticulum (ER) where oxidation/reduction
reactions are critical for protein folding. Indeed, dilation of
the melanocyte ER has been reported in biopsies from the
edge of vitiligo lesions and in melanocytes cultured from
vitiligo patients (Boissy et al., 1991; Le Poole and Boissy,
1997; Le Poole et al., 2000). Subsequent accumulation of
misfolded peptides would then activate the unfolded protein
response (UPR). The UPR, which consists of three pathways
initiated by inositol-requiring enzyme-1 (IRE1), protein kinase
RNA (PKR)-like ER kinase (PERK) and activating transcription
factor-6 (ATF6), respectively, promotes restoration of ER
homeostasis and cell survival, but under sustained stress it
can trigger apoptosis (Ron and Walter, 2007).
The UPR has been implicated in a number of autoimmune
disorders associated with vitiligo such as type 1 diabetes
(Lipson et al., 2006). Similar to our proposed model for
vitiligo, in diabetes, it has been suggested that exposure to
environmental agents such as toxins may be involved in
initiation of excessive ER stress in pancreatic b cells, triggering
an apoptotic cascade by the UPR that leads to autoimmunity
(Lipson et al., 2006; Fonseca et al., 2009). Disruption of the
UPR may contribute to development of autoimmunity
through three possible mechanisms: (1) generation of anti-
gens during degradation of misfolded proteins, (2) release
of neo-antigens by apoptotic cells, and (3) disturbance of
immune-tolerance mechanisms in cells with an abnormal
UPR (Todd et al., 2008).
Involvement of the UPR in the pathogenesis of vitiligo is
suggested by genetic studies, which found that polymorph-
isms in the gene encoding X-box-binding protein 1 (XBP1), a
transcription factor that modulates several downstream UPR
targets, are associated with increased risk of developing the
disease (Ren et al., 2009). Activation of IRE1 by dimerization
and phosphorylation induces splicing of mRNA encoding
XBP1 (Merksamer and Papa, 2010).
The PERK-initiated UPR pathway reduces global protein
synthesis via phosphorylation of the alpha subunit of
eukaryotic initiation factor 2a (EIF2a). Once homeostasis is
restored, EIF2a is dephosphorylated by the growth arrest and
DNA damage-inducible protein, GADD34. PERK also acti-
vates the transcription factors ATF4 and nuclear factor
erythroid 2-related factor 2 (NRF2) (Cullinan and Diehl,
2006). NRF2 regulates the expression of antioxidant-respon-
sive element containing genes including heme oxygenase-1
(HMOX1) (Nguyen et al., 2009), which protects melanocytes
from the deleterious effects of UV as well as 4-TBP (Elassiuty
et al., 2011).
In this study, we investigated the early events in induction
of vitiligo by employing 4-TBP and MBEH, known triggers of
vitiligo, to induce stress in human melanocytes. We show
that exposure of melanocytes to these chemicals can activate
the UPR and lead to enhancement of the antioxidant
response, but also to increased expression of cytokines IL6
and IL8 that may contribute to autoimmune-mediated
progression of vitiligo. This study improves our understanding
of the mechanisms that link environmental stressors and
autoimmunity.
RESULTS
Doses for use in experiments were selected after the toxicities
of 4-TBP and MBEH were determined, using a viability assay,
24 and 72 hours after exposure (Supplementary Figure S1
online). Concentrations of 250 and 300mM were selected for
dosing with 4-TBP and MBEH, respectively, because they
resulted ino20% loss of viability. The rationale for selecting
these doses was to stress cells but not to compromise their
survival significantly, at least in early phases of exposure to
phenols, in order to mimic the outcome of exposure to low
concentrations of these agents in the environment.
There is evidence that, similar to the in vitro response of
melanocytes to phenols, occupational vitiligo induced by
phenols is also dose dependent (James et al., 1977). Humans
are exposed to various concentrations of phenols in the work
environment, however, the precise doses are not known. The
current Occupational Safety and Health Administration
permissible exposure limit for phenol is 5 parts per million.
At these low concentrations, while phenols do not seem to
induce immediate cell death, they act as enzyme inhibitors or
may activate stress signaling pathways such as the UPR.
Furthermore, we have previously shown that, at this dose,
4-TBP generates reactive oxygen species in melanocytes
(Manga et al., 2006).
4-TBP and MBEH induce upregulation of key UPR proteins
We used microarray analysis to investigate UPR-related
changes in gene expression induced by 4-TBP and MBEH.
Gene expression profiles of melanocytes dosed with 4-TBP or
MBEH for 3, 6, and 24 hours were compared with expression
in untreated cells. Of the 38,500 entities analyzed, 3,960
were differentially expressed between treated and untreated
cells (fold-change X3): of these, 176 genes were differen-
tially expressed in both melanocytes dosed with 4-TBP and
those dosed with MBEH (one-way analysis of variance,
Pp0.05) after Benjamini–Hochberg correction for multiple
comparisons. A total of 525 genes were differentially
expressed only in cells dosed with 4-TBP and 3,093 genes
only in cells dosed with MBEH. As both 4-TBP and MBEH are
well known to induce vitiligo, we focused on changes in gene
expression common to both agents.
Key UPR markers were found to be upregulated by
exposure of melanocytes to both 4-TBP and MBEH. These
include IRE1 and PERK; however, the third UPR initiator,
ATF6, was not increased in the presence of either phenol.
These findings were validated using a UPR-focused quanti-
tative PCR array (Supplementary Table S1 online). We also
identified a number of changes in expression of genes that are
not involved in the UPR, and are currently validating these
findings.
Among the genes found to be increased by exposure to
both 4-TBP and MBEH were IL6 and IL8. Gene Ontology
analysis based on gene function demonstrated 4-TBP and
MBEH-induced upregulation of a number of cytokines and
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chemokines; genes involved in antigen processing and
presentation such as ICAM1, which may be involved in
adhesion of leukocytes to melanocytes (Kirnbauer et al.,
1992); and genes reported in association with response to
stressful stimuli in vitiligo such as superoxide dismutase-2
and HMOX1 (Yildirim et al., 2004; Jian et al., 2011)
(Supplementary Table S2 online). The most highly upregu-
lated genes encoded cytokines and chemokines involved in
immune responses. These findings suggest that 4-TBP and
MBEH not only impact melanocyte viability, but may also
contribute to inflammation/autoimmune-mediated progres-
sion of vitiligo.
4-TBP and MBEH induce an antioxidant response mediated by
PERK and NRF2
PERK activation attenuates global protein synthesis via
phosphorylation of EIF2a and an increase in ATF4 expression.
Activation of this pathway mediates an antioxidant response
through activation of the transcription factor NRF2. NRF2 is
recruited to the nucleus where it regulates the expression of
the antioxidant HMOX1. Levels of phospho-EIF2a have been
shown to correlate with nuclear localization of NRF2 (Shiota
et al., 2010).
We have shown that exposure to 4-TBP or MBEH causes
an increase in expression of PERK and its downstream target
ATF4 (Figure 1a and Supplementary Table S1 online) as well
as an increase in phosphorylation of EIF2a (Figure 1b). Sub-
cellular fractionation and western blot analysis demonstrate
that melanocyte exposure to either 4-TBP or MBEH results in
increased nuclear localization of NRF2 (Figure 1c) and
mRNA expression of the antioxidant response regulator
HMOX1 is increased (Figure 1d and e) compared with
untreated cells, indicating that melanocytes mount an
antioxidant response to both compounds.
Guanabenz binds to the protein phosphatase 1
(PPP1R15A)/growth arrest and DNA damage-inducible
protein (GADD34) complex, disrupting dephosphorylation
of EIF2a, and potentiating PERK signaling (Tsaytler et al.,
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Figure 1. Treatment with 4-tertiary butyl phenol (4-TBP) or monobenzyl ether of hydroquinone (MBEH) induces activation of the protein kinase RNA (PKR)-
like ER kinase (PERK) and NF erythroid 2-related factor 2 (NRF2)/heme oxygenase-1 (HMOX1) pathways in human melanocytes. (a) Quantitative real-time
PCR indicates that mRNA levels of PERK and activating transcription factor 4 (ATF4) are increased in human melanocytes treated with exposure to either 4-TBP
or MBEH versus controls (*Po0.01 vs. 0 hours). (b) Western blot analysis demonstrates increased levels of phosphorylated eukaryotic initiation factor 2a (EIF2a)
in melanocytes following treatment with either 4-TBP or MBEH confirming unfolded protein response (UPR) activation. (c) Western blot analysis of cytoplasmic
and nuclear extracts of melanocytes shows a greater nuclear fraction of NRF2 following treatment with either 4-TBP or MBEH. (d) Both semi-quantitative reverse
transcriptase (RT)–PCR and (e) quantitative real-time PCR demonstrate that mRNA levels of HMOX1 are increased following dosing with 4-TBP or MBEH and
when dephosphorylation of EIF2a is inhibited with guanabenz, HMOX1 expression levels remain increased (*Po0.001 vs. 0 hours). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH)¼ loading control. GADD34, growth arrest and DNA damage-inducible protein.
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2011). Co-treatment of melanocytes with either 4-TBP or
MBEH in combination with guanabenz resulted in increased
HMOX1 (Figure 1d and e), supporting a role for PERK in the
regulation of this key antioxidant enzyme.
Increased cytokine expression and secretion stimulated by
vitiligo-inducing phenols
To validate our finding that the expression of certain
cytokines, identified by microarray analysis, increases fol-
lowing exposure to vitiligo-inducing phenols, we performed
quantitative reverse transcriptase (RT)–PCR array of 84
cytokines in cells treated with 4-TBP. Nineteen genes were
upregulated significantly (Po0.05) at one or more of the three
time points of the study (Supplementary Table S3 online).
Results were confirmed using quantitative RT–PCR of
individual mRNAs. Following 4-TBP treatment, IL6 and IL8
expression were significantly upregulated at 3 and 6 hours
after treatment, while their expression was downregulated
24 hours after treatment (Figure 2a), validating the microarray
data.
4-TBP and MBEH induce production of IL6 and IL8 via the UPR
We performed western blot analysis to investigate IRE
expression and phosphorylation and semi-quantitative
RT–PCR to assess XBP1 expression and splicing. Increased
expression and phosphorylation of IRE1 by melanocytes was
detected within 3 hours following 4-TBP or MBEH dosing
(Figure 2b), concomitant with increased splicing of XBP1
(Figure 2c), leading to its expression, and indicating activa-
tion of the UPR following treatment with either 4-TBP or
MBEH. Thus, 4-TBP and MBEH induce activation of the IRE1-
XBP1 arm of the UPR.
IL6 and IL8 expression is regulated in part by XBP1
(Gargalovic et al., 2006). Western blot analysis of proteins in
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Figure 2. Treatment of melanocytes with 4-tertiary butyl phenol (4-TBP) or monobenzyl ether of hydroquinone (MBEH) results in increased production of IL6
and IL8 by human melanocytes because of activation of the inositol-requiring enzyme-1 (IRE1)-initiated arm of the unfolded protein response (UPR).
(a) Quantitative real-time PCR demonstrates that mRNA levels of IL6 and IL8 are increased in human melanocytes treated with 4-TBP versus controls (average of
four experiments, two melanocyte lines, *Po0.001 vs. 0 hours). (b) Western blot analysis of cell lysates collected from human melanocytes treated with 4-TBP,
MBEH, and thapsigargin (TG) showed increased expression of phosphorylated IRE1. (c) Semi-quantitative reverse transcriptase (RT)-PCR of RNA from human
melanocytes treated with 4-TBP, MBEH, and TG showed increased splicing of X-box-binding protein 1 (XBP1) compared with control cells. (d) Western blotting
of concentrated media collected from human melanocytes treated with 4-TBP or MBEH showed increased secretion of IL6 and IL8. Purified IL6 (Santa Cruz
Biotechnology, Santa Cruz, CA), was used as a positive control. Three experiments with two different melanocyte lines yielded similar result. Three experiments
performed with two different melanocyte lines, from unrelated donors, yielded similar results.
2604 Journal of Investigative Dermatology (2012), Volume 132
S Toosi et al.
Phenols Induce IL6 and IL8 Expression in Melanocytes via the UPR
the culture medium showed that within 3 hours of exposure
to 4-TBP or MBEH, both IL6 and IL8 secretion by treated
melanocytes was substantially higher than secretion by cells
subjected to vehicle alone, thus correlating with activation of
the IRE1 arm of the UPR (Figure 2d). Thapsigargin, an
inhibitor of sarco/ER calcium ATPases, and a well-known
inducer of the UPR, was used as a positive control.
Two inhibitors of XBP1 splicing, salicylaldehyde (SA)
(Volkmann et al., 2011) and rapamycin, were used to block
the IRE1 arm of the UPR in melanocytes before and
concomitant with treatment with 4-TBP or MBEH. Although
rapamycin is a well-known inhibitor of the mammalian target
of rapamycin, it has also been shown to inhibit XBP1 splicing
(Pfaffenbach et al., 2010). Results of the RT–PCR experiments
show that pre-treatment with both SA and rapamycin
abrogated XBP1 splicing that follows exposure of melano-
cytes to 4-TBP or MBEH (Figure 3a). Quantitative PCR
showed that when no inhibitor was added, 4-TBP and MBEH
led to 9- and 9.4-fold increase in IL6 expression, respectively,
compared with that seen in control cultures (Figure 3b).
When XBP1 splicing was inhibited with SA, the levels of IL6
expression were markedly lowered to 0.9- and 2.2-fold,
respectively, and to 0.9- and 1.3-fold expression, respec-
tively, when rapamycin was used. Similarly, treatment with
SA reduced the induction of IL8 by 4-TBP and MBEH from
5.9- and 6.8-fold to 3.6- and 1.9- expression, respectively,
and to 2.5- and 2.4-fold expression, respectively, when
rapamycin was used.
To determine if XBP1 indeed mediated the increase in IL6
and IL8 expression, melanocytes were transfected with an
expression vector containing the coding sequence of XBP1.
Semi-quantitative RT–PCR showed that—similar to the effects
observed with phenols—XBP1 overexpression was correlated
with an increased expression of both IL6 and IL8 (Figure 3c).
These results showed that activation of XBP1, a key step in
the UPR pathway, is involved in 4-TBP and MBEH-induced
expression of IL6 and IL8 in melanocytes.
DISCUSSION
Oxidative stress and autoimmunity are key factors in the
pathogenesis of vitiligo. In this study, we demonstrate that
stress response pathways activated by disruption of the
cellular redox balance can induce both cellular antioxidant
responses as well as expression of cytokines that may provoke
an autoimmune-mediated progression of vitiligo.
A role for oxidative stress in vitiligo is supported by
numerous studies. Antioxidant levels are elevated in sera
from patients with vitiligo (Yildirim et al., 2003), while
cultured melanocytes from patients are more susceptible to
oxidative stress (Manga et al., 2006). We hypothesized that
oxidative stress in melanocytes leads to disruption of the
folding machinery of the ER, which is dependent on redox
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Figure 3. 4-Tertiary butyl phenol (4-TBP) and monobenzyl ether of hydroquinone (MBEH) induce production of IL6 and IL8 via the inositol-requiring enzyme-
1 (IRE1)–X-box-binding protein 1 (XBP1) arm of the unfolded protein response (UPR). Melanocytes were pre-treated with salicylaldehyde (SA) and rapamycin,
chemical inhibitors of XBP1 splicing, resulting in reduced production of IL6 and IL8 following treatment with 4-TBP and MBEH. (a) Reverse transcriptase (RT)-
PCR shows that pre-treatment with either SA or rapamycin can abrogate XBP1 splicing that follows exposure of melanocytes to 4-TBP or MBEH. (b) Quantitative
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reactions for formation of disulphide bonds. In support of this
idea is ER dilation in melanocytes at the periphery of vitiligo
lesions and in melanocytes cultured from vitiligo patients
(Boissy et al., 1991; Im et al., 1994; Le Poole et al., 2000).
Accumulation of immature proteins in the ER results in
activation of the UPR, a pathway also implicated in
determining susceptibility to vitiligo in genetic association
studies linking an XBP1 polymorphism with increased risk of
developing the disorder (Ren et al., 2009). Results of this
study provide evidence that the UPR is indeed activated by
exposure of melanocytes to 4-TBP and MBEH, agents known
to trigger vitiligo.
UPR activation is initially a cell survival mechanism.
Initiation of PERK signaling leads to the recruitment of NRF2
to the nucleus and expression of the antioxidant enzyme
HMOX1 (Cullinan and Diehl, 2004). We show that vitiligo-
inducing phenols cause nuclear relocalization of NRF2 and
HMOX1 expression. Sustained PERK signaling by inhibition
of EIF2a dephosphorylation results in increased HMOX1
expression. Activation of the NRF2/HMOX1 pathway may
have a role in reducing oxidative damage induced by
phenolic compounds in human melanocytes. Activation of
this pathway may be of particular importance in vitiligo as
HMOX1 expression has been associated with suppression of
dendritic cells that affect cytotoxic T-cell responses (Listopad
et al., 2007). Both cell types contribute to melanocyte killing
in vitiligo lesions (Kroll et al., 2005; van den Boorn et al.,
2009). Thus, PERK activation may reduce the toxicity of
vitiligo-inducing phenols.
It has been suggested that 4-TBP and MBEH-induced
melanocyte death results in activation of an autoimmune
response in vitiligo, although 4-TBP has been shown to
induce apoptosis, while MBEH is thought to induce necrosis
(Hariharan et al., 2010). We therefore focused on those
events that were common to cells treated with both 4-TBP
and MBEH.
UPR signaling in endothelial cells has been shown to
induce IL6 and IL8 expression (Gargalovic et al., 2006). We
found that both 4-TBP and MBEH caused increased produc-
tion of IL6 and IL8. Pre-treatment of melanocytes with
inhibitors of XBP1 activation resulted in decreased produc-
tion of IL6 and IL8 following exposure to 4-TBP and MBEH.
Moreover, transfection with an XBP1 vector was associated
with increased expression of IL6 and IL8 similar to the effects
observed with phenols. Thus, these vitiligo-inducing chemi-
cals share in common the activation of a stress signaling
pathway, which may be associated with an autoimmune
response independent from these agents’ direct chemotoxic
effects.
The UPR may, therefore, serve as a key link between
oxidative stress and production of pro-inflammatory cyto-
kines, such as IL6 and IL8, which may promote autoimmune
targeting of melanocytes. Increased IL6 has been found in
sera of vitiligo patients (Yu et al., 1997; Tu et al., 2003) and
lesional vitiligo tissues (Moretti et al., 2009). IL6 is one of the
key molecules that stimulate the immune reactions (Ishihara
and Hirano, 2002) and stimulates T lymphocytes that induce
autoimmune diseases (Gabay, 2006). Increased serum and/or
tissue levels of IL6 have been documented in various
autoimmune disorders associated with vitiligo (Kogiso et al.,
1992; Norose et al., 1994; Salvi et al., 1996; Alexandraki
et al., 2008). A molecular link between oxidative stress and
autoimmune conditions such as age-related macular degen-
eration has been suggested by reports of increased production
of IL6 from retinal melanocytes following stimulation
with hydrogen peroxide (Wu et al., 2010), supporting our
hypothesis that UPR-mediated expression of IL6 links
melanocyte stress and immune targeting of these cells.
Moreover, IL6 significantly upregulates melanocyte ICAM1
expression (Kirnbauer et al., 1992), which may facilitate
leukocyte–melanocyte attachment and immunologic cytotoxi-
city. In this study, 4-TBP and MBEH also induced expression
of ICAM1 (Supplementary Table S2 online). Similarly, levels
of IL8, a cytokine with prominent chemotactic activity,
are elevated in sera of vitiligo patients (Yu et al., 1997)
and melanocytes produce IL8 following stimulation by
anti-melanocyte IgG antibodies (Li et al., 2000), which are
present in most patients with vitiligo (Kemp et al., 2001). IL8
may attract T cells to vitiligo lesions leading to amplification
of the inflammatory reaction and melanocyte death. Addi-
tionally, it has been shown that IL6 and IL8 may also directly
inhibit the growth and modulate antigen expression of
melanocytes (Krasagakis et al., 1995).
A variety of skin cells including keratinocytes, endothelial
cells, and fibroblasts as well as immune cells that are present
in vitiligo tissue such as T cells and dendritic cells are known
to release IL6 and IL8. Although each of these cells may
contribute to the cytokine environment, dermatitis following
exposure to vitiligo-inducing phenols depends on the pre-
sence of melanocytes in the skin (Nordlund et al., 1985).
Thus, production of inflammatory cytokines from the
melanocytes may be of particular relevance to the pathogen-
esis of vitiligo. Furthermore, early increases in expression of
IL6 and IL8 following exposure to 4-TBP and MBEH,
observed in our study, suggests a possible contributory role
for these cytokines in the transition from chemical-induced
melanocyte death to a persistent autoimmune condition as
observed in vitiligo. Our data demonstrate that in addition to
IL6 and IL8, following treatment with phenols, melanocytes
show increased expression of a variety of other immune
response molecules. A number of these molecules have pro-
inflammatory activities and may have a role in progression of
vitiligo. In particular, IL11 is a pro-inflammatory cytokine that
has IL6-like activity (Guk and Kuprash, 2011) and tumor
necrosis factor is found in tissues obtained from vitiligo
patients (Birol et al., 2006). Thus, additional pathways
contribute to the initiation of vitiligo. This is not surprising
given the complex etiology of the disorder.
In summary, our findings support the hypothesis that
activation of the ER-stress response has a role in the
pathogenesis of vitiligo and propose the following model:
vitiligo-inducing traumas cause oxidative stress in melano-
cytes leading to ER stress and activation of the UPR. Signaling
via the UPR enhances the NRF2/HMOX1 antioxidant response
and allows restoration of homeostasis. Individuals susceptible
to vitiligo—e.g., because of their genetic background—are
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unable to sufficiently combat the oxidative stress, leading to
sustained UPR activity, including IL6 and IL8 production. As
a consequence, the persistent alterations in the immunolo-
gical microenvironment of the skin, in combination with
increased immunogenicity caused by phenols (van den Boorn
et al., 2011), may contribute to enhancement and expansion
of vitiligo lesions. Thus, the UPR may have a critical role in
determining melanocyte viability following exposure to a
vitiligo-inducing stressor and in the progression to an immune
response that targets the melanocyte.
MATERIALS AND METHODS
Cell cultures and viability assay
Two lines of human melanocytes derived from normal neonatal skin
(unrelated individuals) were obtained from Lifeline Cell Technology
(Walkersville, MD) and cultured in Dermalife M melanocyte culture
medium from the same company. Cells were treated with
1–1,000 mM 4-TBP or MBEH for 24 and 72 hours and a CellTiter96
assay (Promega, Madison, WI) was performed to assess cellular
viability. Melanocytes were also treated with 150 nM thapsigargin,
which was used where noted as a positive control for induction of
ER-stress response.
Microarray analysis
Individual total RNA samples from human melanocytes dosed with
4-TBP or MBEH for 3, 6, and 24 hours, as well as control cells before
treatment were hybridized to Affymetrix Gene Chip Human Genome
U133 Plus.2 (Agilent Technologies, Santa Clara, CA). Hybridization
and processing was performed by the Genomics, Microarray Core
Facility, New York University School of Medicine, New York, NY.
We analyzed the results using the Genespring GX 11.0 software
(Agilent Technologies). Data have been deposited in the NCBI
microarray database (https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE31641).
Quantitative real-time PCR
Total RNA was isolated from cell lysates using RNeasy Mini kit
(Qiagen, Valencia, CA). Complementary DNA was generated
using the RT2 First Strand Kit (SABiosciences, Valencia, CA). Two
RT2 Profiler PCR Arrays were used to examine mRNA levels of
human cytokines and UPR genes (SABiosciences). Real-time PCR
was performed on an Applied Biosystems 7900 HT machine with
SYBR Green RT2/ROX PCR Master Mix solution (SABiosciences)
following the manufacturer’s recommended PCR conditions. The
average threshold cycle for each gene was determined from four
independent experiments from each cell line. Values were
exported to a template Excel file for analysis provided by the
manufacturer.
Quantitative real-time PCR of IL6 and IL8 for the activation
analysis with UPR inhibitors was performed using MyiQ2 system
(Bio-Rad Laboratories, Hercules, CA). SYBR Green RT2 /ROX PCR
Master Mix solution (SABiosciences) was used for PCR reaction and
forward and reverse primers were purchased from Sigma-Aldrich (St
Louis, MO). Data were obtained as Ct values and analyses were
performed by the manufacturer’s software. All reactions were
performed in triplicate and the results are expressed as the mean
of values from two separate experiments.
Western blot analysis
For protein extraction, cells were harvested in a Tris-base extraction
buffer containing protease inhibitor. Fractionation of the cytoplasmic
and nuclear NRF2 protein was performed using the NE-PER
extraction reagents (Thermo Scientific Pierce, Rockford, IL) accord-
ing to the manufacturer’s instructions. ILs were detected in the
supernatant media of cultured cells. Equal numbers of cells, 2 106
per sample, were cultured in 5ml media that was subsequently
collected and after brief centrifugation was concentrated using
filtered centrifuge columns. After normalization with the total
amount of protein in cell lysates, equal amounts of protein (for IL6
and IL8 detection) were loaded to each well for western blot
analysis. Protein concentrations were measured with bicinchoninic
acid protein assay. In all, 20–40mg of total protein were loaded and
separated on 10–12% SDS-PAGE gels and then transferred to
nitrocellulose membrane (Polyscreen; Perkin-Elmer, Waltham,
MA). After blocking with 5% nonfat milk in Tris-buffered saline
and 0.1% Tween 20, membranes were incubated overnight at 4 1C
with the following primary antibodies: mouse monoclonal anti-
bodies for IL6 (1:500) and IL8 (1:500) (Santa Cruz Biotechnology,
Santa Cruz, CA), IRE1 (1:1,000) and EIF2a (1:5,000) and rabbit
monoclonal phospho-EIF2a (1:1,000) (Cell Signaling, Danvers, MA),
NRF2 (1:2,000) (R&D Systems, Minneapolis, MN), and rabbit
polyclonal phospho-IRE1 (1:1,000) (Novus Biologicals, Littleton,
CO) and phospho-EIF2a (Cell Signaling). After washing, membranes
were incubated for 1 hour at room temperature with horseradish
peroxidase-conjugated secondary antibodies. The immunoblots
were developed using the enhanced chemoluminescence detection
system (Amersham, Arlington Heights, IL). Actin (detected with
mouse monoclonal anti-actin (1:10,000) (Sigma-Aldrich)) and
histone H1 (detected with goat anti-histone H1 (1:1,000) (Santa
Cruz Biotechnology)) were used as loading controls.
Reverse transcription-PCR
XBP1 splicing and IL6, IL8, and HMOX1 transcript expression were
assessed by semi-quantitative RT–PCR. Cells were lysed and total
RNA was isolated with RNeasy Mini kit (Qiagen). Following
quantification, 1 mg of RNA was used to generate complementary
DNA using ImProm-II Reverse Transcription System (Promega,
Madison, WI). RT–PCR was performed using the Gotaq assay kit in
a Bio-Rad MJ mini personal thermal cycler PCR System (Life Science
Research, Hercules, CA). To differentiate the unspliced form of XBP1
from the spliced form, PCR products were incubated with Pst1
enzyme (New England BioLabs, Ipswich, MA). The PCR products
were separated on a 2% agarose gel and visualized by ethidium
bromide staining. The unspliced XBP1 produced two 290- and 183-
bp fragments while the spliced Xbp-1 generated a 447-bp fragment.
IL6, IL8, and HMOX1 produced 223-, 335-, and 157-bp bands,
respectively. As the loading control, glyceraldehyde-3-phosphate
dehydrogenase and RPL13A were used.
Analyses using modulators of the UPR
On the basis of the findings in preliminary RT–PCR and western blot
studies, exposures in the presence of chemical inhibitors of XBP1
splicing were performed to confirm any potential role of UPR on any
4-TBP or MBEH-induced effects on human melanocytes. In these
experiments, cells were exposed to 80mM SA or 100 nM rapamycin
3 hours before exposure to 4-TBP or MBEH. The role of PERK pathway
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in production of IL6 and IL8 by human melanocytes was examined
using guanabenz, a selective inhibitor of protein phosphatase 1 with
protective effects against accumulation of misfolded proteins
(Tsaytler et al., 2011). Cells were pre-treated with 50 mM guanabenz
for 1 hour before being exposed to 4-TBP or MBEH.
Transient transfection with XBP1
A human XBP1 expression vector was purchased from the Arizona
State University (Biodesign Institute, Tempe, AZ). The XBP1
complementary DNA was subcloned into the pcDNA3.2 expres-
sion vector (Invitrogen, Carlsbad, CA) and purified using the
Qiagen Miniprep kit. DNA electroporation was performed using
the Amaxa NHEM-Neo Kit (Lonza, Walkersville, MD). Each 0.5
million cells were transfected with 1 mg of purified expression
vector or empty vector, as a control, according to the manufac-
turer’s instructions. Dosing with 4-TBP was performed 48 hours
after transfection and thapsigargin was used as a positive control
for the UPR activation.
Statistical analysis
Data are presented as mean±SD. Statistical significance was
assessed using a two-sided t-test. Po0.05 was considered statisti-
cally significant.
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